As on date of publishing, this report will capture the impact assessment of COVID-19 on this market and the same will be considered in our market forecast model. Clients purchasing this report between April and June 2020 will be getting a ‘free’ updated market data excel sheet between July and September 2020 accounting for the impact of COVID-19 on the market in the current year 2020 and forecast.

Global clinical trials market is expected to witness robust CAGR during the forecast period owing to outbreak of tropical and infectious diseases such as COVID-19, that has led to extensive clinical trials around the world in order to find the suitable treatment and vaccine. The growing adoption of virtual clinical trials that allow to collect data еffісіеntlу and safely from раrtісіраntѕ, without requirement of traveling to the lab or hospital is also acting as major growth driver for global clinical trials market. Moreover, growing prevalence of nеurоlоgісаl dіѕеаѕеѕ such as Раrkіnѕоn’ѕ, Аlzhеіmеr’s, tumors and dерrеѕѕіоn, coupled with growing geriatric population are some other key factors creating the need for clinical trials. Also, digitalization of clinical trials is anticipated to propel the growth of this market in coming years.

Additionally, increasing prevalence of chronic diseases and growing need for personalized drugs are some other key factors propelling the growth of global clinical trials market. Governments in various economies are also providing favorable support for clinical trials in order to find the cure for deadly diseases like coronavirus. The increasing expenditure on R&D activities and rise in biotechnology firms is also anticipated to drive the market growth through 2025.

Global clinical trials market can be segmented based on phase, study design, indication, end user and region. Based on indication, the market can be segmented into autoimmune, blood disorders, pain management, oncology, CNS condition, diabetes, obesity, cardiovascular and others. Among these, the oncology segment is expected to undergo fastest CAGR during the forecast period owing to increasing expenditure by medical industry towards preclinical and clinical development of oncology drugs.

Regionally, Asia Pacific is anticipated to witness fastest CAGR through 2025 owing to large patient pool suffering from coronavirus and increasing number of biotechnology firms undergoing COVID-19 trials. The favourable support by governments in countries such as India and South Korea, is also leading to extensive clinical trials in the two countries.

Major companies operating in global clinical trials market include Еlі Lіllу аnd Соmраnу, Clinipace Worldwide, Ѕun Рhаrmасеutісаl Іnduѕtrіеѕ Ltd., Nоvо Nоrdіѕk А/Ѕ, Рfіzеr Іnс., GlaxoSmithKline, ІСОN рlс, Sanofi Aventis A.S., Quintiles IMS Holdings, Pharmaceutical Product Development LLC, Ноffmаnn-Lа Rосhе Ltd., Aaipharma Services Corp, РАRЕХЕL Іntеrnаtіоnаl Соrроrаtіоn, ІQVІА Ноldіngѕ Іnс., Accell Clinical Research LLC, Omnicare Inc., IGATE Inc., Charles River Laboratories, Covance Inc. and Accovion GmbH, among others. The market players are undertaking growth strategies such as mergers & acquisitions along with new product launches to increase their share in global market.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021–2025

Objective of the Study:

  • To analyze and forecast the market size of global clinical trials market.
  • To forecast global clinical trials market based on phase, study design, indication, end user, company and regional distribution.
  • To identify drivers and challenges for global clinical trials market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions etc. in global clinical trials market.
  • To identify and analyze the profile of leading players operating in the global clinical trials market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of clinical trial companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research.

TechSci Research calculated global clinical trials market size using a bottom-up approach, where data for various end user industries and its application across various product types were recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also used by TechSci Research.

Key Target Audience:

  • Clinical trials service providers, companies/partners and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, industry associations, forums and alliances related to clinical trials
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as clinical trials service provider companies, end users etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global clinical trials market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Clinical Trials Market, By Phase:
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • Global Clinical Trials Market, By Study Design:
    • Interventional
    • Treatment Studies
    • Observational
    • Expanded Access
  • Global Clinical Trials Market, By Indication:
    • Autoimmune
    • Blood Disorders
    • Pain Management
    • Oncology
    • CNS Condition
    • Diabetes
    • Obesity
    • Cardiovascular
    • Others
  • Global Clinical Trials Market, By End User:
    • Hospital
    • Laboratories
    • Clinics
  • Global Clinical Trials Market, By Region:
    • Asia-Pacific
      • China
      • Japan
      • India 
      • South Korea
      • Australia
    • Europe
      • France
      • Germany
      • United Kingdom
      • Italy
      • Spain
    • North America
      • United States
      • Mexico
      • Canada
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global clinical trials market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Profit Margin Analysis

  • Profit margin analysis in case of direct and indirect sales channel.
It is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com  

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Clinical Trials Phase Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Clinical Trials Market

4.    Executive Summary

5.    Voice of Customer

6.    Global Clinical Trials Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value & Volume

6.2.  Market Share & Forecast

6.2.1.     By Phase (Phase I, Phase II, Phase III, Phase IV)

6.2.2.     By Study Design (Interventional, Treatment Studies, Observational, Expanded Access)

6.2.3.     By Indication (Autoimmune, Blood Disorders, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, Others)

6.2.4.     By End User (Hospital, Laboratories, Clinics)

6.2.5.     By Company (2019)

6.2.6.     By Region

6.3.  Phase Market Map

7.    Asia-Pacific Clinical Trials Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Phase

7.2.2.     By Study Design

7.2.3.     By Indication

7.2.4.     By End User

7.2.5.     By Country

7.3.  Asia-Pacific: Country Analysis

7.3.1.     China Clinical Trials Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value & Volume

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Phase

7.3.1.2.2.             By Study Design

7.3.1.2.3.             By Indication

7.3.1.2.4.             By End User

7.3.2.     India Clinical Trials Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value & Volume

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Phase

7.3.2.2.2.             By Study Design

7.3.2.2.3.             By Indication

7.3.2.2.4.             By End User

7.3.3.     Japan Clinical Trials Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value & Volume

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Phase

7.3.3.2.2.             By Study Design

7.3.3.2.3.             By Indication

7.3.3.2.4.             By End User

7.3.4.     South Korea Clinical Trials Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value & Volume

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Phase

7.3.4.2.2.             By Study Design

7.3.4.2.3.             By Indication

7.3.4.2.4.             By End User

7.3.5.     Australia Clinical Trials Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value & Volume

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.             By Phase

7.3.5.2.2.             By Study Design

7.3.5.2.3.             By Indication

7.3.5.2.4.             By End User

8.    Europe Clinical Trials Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value & Volume

8.2.  Market Share & Forecast

8.2.1.     By Phase

8.2.2.     By Study Design

8.2.3.     By Indication

8.2.4.     By End User

8.2.5.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France Clinical Trials Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value & Volume

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Phase

8.3.1.2.2.             By Study Design

8.3.1.2.3.             By Indication

8.3.1.2.4.             By End User

8.3.2.     Germany Clinical Trials Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value & Volume

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Phase

8.3.2.2.2.             By Study Design

8.3.2.2.3.             By Indication

8.3.2.2.4.             By End User

8.3.3.     United Kingdom Clinical Trials Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value & Volume

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Phase

8.3.3.2.2.             By Study Design

8.3.3.2.3.             By Indication

8.3.3.2.4.             By End User

8.3.4.     Italy Clinical Trials Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value & Volume

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Phase

8.3.4.2.2.             By Study Design

8.3.4.2.3.             By Indication

8.3.4.2.4.             By End User

8.3.5.     Spain Clinical Trials Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value & Volume

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Phase

8.3.5.2.2.             By Study Design

8.3.5.2.3.             By Indication

8.3.5.2.4.             By End User

9.    North America Clinical Trials Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value & Volume

9.2.  Market Share & Forecast

9.2.1.     By Phase

9.2.2.     By Study Design

9.2.3.     By Indication

9.2.4.     By End User

9.2.5.     By Country

9.3.  North America: Country Analysis

9.3.1.     United States Clinical Trials Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value & Volume

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Phase

9.3.1.2.2.             By Study Design

9.3.1.2.3.             By Indication

9.3.1.2.4.             By End User

9.3.2.     Mexico Clinical Trials Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value & Volume

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Phase

9.3.2.2.2.             By Study Design

9.3.2.2.3.             By Indication

9.3.2.2.4.             By End User

9.3.3.     Canada Clinical Trials Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value & Volume

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Phase

9.3.3.2.2.             By Study Design

9.3.3.2.3.             By Indication

9.3.3.2.4.             By End User

10.  South America Clinical Trials Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value & Volume

10.2.              Market Share & Forecast

10.2.1.  By Phase

10.2.2.  By Study Design

10.2.3.  By Indication

10.2.4.  By End User

10.2.5.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Clinical Trials Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value & Volume

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Phase

10.3.1.2.2.           By Study Design

10.3.1.2.3.           By Indication

10.3.1.2.4.           By End User

10.3.2.  Argentina Clinical Trials Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value & Volume

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Phase

10.3.2.2.2.           By Study Design

10.3.2.2.3.           By Indication

10.3.2.2.4.           By End User

10.3.3.  Colombia Clinical Trials Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value & Volume

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Phase

10.3.3.2.2.           By Study Design

10.3.3.2.3.           By Indication

10.3.3.2.4.           By End User

11.  Middle East and Africa Clinical Trials Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value & Volume

11.2.              Market Share & Forecast

11.2.1.  By Phase

11.2.2.  By Study Design

11.2.3.  By Indication

11.2.4.  By End User

11.2.5.  By Country

11.3.              MEA: Country Analysis

11.3.1.  South Africa Clinical Trials Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value & Volume

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Phase

11.3.1.2.2.           By Study Design

11.3.1.2.3.           By Indication

11.3.1.2.4.           By End User

11.3.2.  Saudi Arabia Clinical Trials Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value & Volume

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Phase

11.3.2.2.2.           By Study Design

11.3.2.2.3.           By Indication

11.3.2.2.4.           By End User

11.3.3.  UAE Clinical Trials Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value & Volume

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Phase

11.3.3.2.2.           By Study Design

11.3.3.2.3.           By Indication

11.3.3.2.4.           By End User

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.              Competition Outlook

14.2.              Players Profiled (Leading Companies)

14.2.1.  Еlі Lіllу аnd Соmраnу

14.2.2.  Clinipace Worldwide

14.2.3.  Ѕun Рhаrmасеutісаl Іnduѕtrіеѕ Ltd.

14.2.4.  Nоvо Nоrdіѕk А/Ѕ

14.2.5.  Рfіzеr Іnс.

14.2.6.  GlaxoSmithKline

14.2.7.  ІСОN рlс

14.2.8.  Sanofi Aventis A.S.

14.2.9.  Quintiles IMS Holdings

14.2.10.                Pharmaceutical Product Development LLC

14.2.11.                Ноffmаnn-Lа Rосhе Ltd.

14.2.12.                Aaipharma Services Corp

14.2.13.                РАRЕХЕL Іntеrnаtіоnаl Соrроrаtіоn

14.2.14.                ІQVІА Ноldіngѕ Іnс.

14.2.15.                Accell Clinical Research LLC

14.2.16.                Omnicare Inc.

14.2.17.                IGATE Inc.

14.2.18.                Charles River Laboratories

14.2.19.                Covance Inc.

14.2.20.                Accovion GmbH

15.  Strategic Recommendations

16. About Us & Disclaimer

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com